[Importance of Innerfield's serum test in the diagnosis of prethrombotic and thrombotic states in various cardiovascular diseases]. 1978

G V Andreenko, and V M Panchenko, and M A Karabasova, and V M Bazgadze

To appraise the diagnostic significance of Innerfield's serum test, 40 patients with ischemic heart disease were examined; 18 of them had angina pectoris, 22 myocardial infarction, in the acute of subacute stage, 15 hypertensive disease, and 27 patients had rheumatic heart disease. It is shown that the blood fibrinolytic system was depressed in most patients. A shorter serum test time was characteristic of these diseases when their course was complicated by thromboembolism. With due consideration for the data on the state of the blood coagulation and anticoagulation systems, the serum test may be used for identifying the prethrombotic condition in patients with various cardiovascular diseases.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D005260 Female Females
D005338 Fibrin Fibrinogen Degradation Products Soluble protein fragments formed by the proteolytic action of plasmin on fibrin or fibrinogen. FDP and their complexes profoundly impair the hemostatic process and are a major cause of hemorrhage in intravascular coagulation and fibrinolysis. Antithrombin VI,Fibrin Degradation Product,Fibrin Degradation Products,Fibrin Fibrinogen Split Products,Degradation Product, Fibrin,Degradation Products, Fibrin,Product, Fibrin Degradation
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

G V Andreenko, and V M Panchenko, and M A Karabasova, and V M Bazgadze
January 1979, Annals of clinical and laboratory science,
G V Andreenko, and V M Panchenko, and M A Karabasova, and V M Bazgadze
July 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
G V Andreenko, and V M Panchenko, and M A Karabasova, and V M Bazgadze
January 1979, Terapevticheskii arkhiv,
G V Andreenko, and V M Panchenko, and M A Karabasova, and V M Bazgadze
January 1965, Laboratornoe delo,
G V Andreenko, and V M Panchenko, and M A Karabasova, and V M Bazgadze
March 1971, Vrachebnoe delo,
G V Andreenko, and V M Panchenko, and M A Karabasova, and V M Bazgadze
January 1991, La Pediatria medica e chirurgica : Medical and surgical pediatrics,
G V Andreenko, and V M Panchenko, and M A Karabasova, and V M Bazgadze
July 1980, Klinicheskaia meditsina,
G V Andreenko, and V M Panchenko, and M A Karabasova, and V M Bazgadze
May 1985, Minerva cardioangiologica,
G V Andreenko, and V M Panchenko, and M A Karabasova, and V M Bazgadze
January 1963, Bratislavske lekarske listy,
G V Andreenko, and V M Panchenko, and M A Karabasova, and V M Bazgadze
July 1952, Rassegna internazionale di clinica e terapia,
Copied contents to your clipboard!